Noriday 28 (Norethisterone): Supply issue
There is a supply issue affecting Noriday 28 oral contraceptive (Pharmacode 398322)
18 November 2024 | Update
Stock of Norethinderone is running low. Pfizer is bringing in some of its UK stock to ensure people can continue to access this product. The product is the same as the New Zealand Noriday 28, with some labelling differences.
It has been approved by Medsafe for sale until the New Zealand product is available again.
Affected product
Due to an unexpected delay in sourcing the active ingredient, norethisterone, there is a supply issue affecting Noriday 28 Day oral contraceptive.
- Chemical: Norethisterone
- Presentation: Tab 350 mcg
- Brand: Noriday 28
- Pharmacode: 398322
- Subsidy: $12.25
- Measure / Qty: per 84
Schedule listing for Noriday 28(external link)
Three-month dispensing
All-at-once (stat) dispensing does not currently apply to this product. People can only collect three-months' supply at a time. We will reconsider all-at-once dispensing once the stock situation is resolved.
Alternative product
Noriday 28 UK
From 1 December 2024, we are listing the UK version of Pfizer's Noriday 28 product.
- Brand: Noriday
- Pharmacode: 2695618
- Subsidy: $12.25
- Measure / Qty: per 84
Medsafe has approved it for sale in New Zealand.
- Noriday 28 Supply issue | UK Noriday Nov 24 [PDF 68 KB]
Norethindrone
Norethindrone Tablets USP (pharmacode 2685051) was funded from 1 September 2024. They were Medsafe-approved from 25 September 2024.
This product comes from the United States. It contains the same active ingredient in the same quantity. However, it uses the American name for norethisterone, which is norethindrone.
A brand switch fee will apply from 1 October 2024.
Norethisterone
- Presentation: Tablets 350 mcg
- Brand: Norethinderone - CDC
- Pharmacode: 2685051
- Subsidy: 12.25
- Measure / Qty: per 84
A5 flier about the temporary brand change
- Noriday 28 | Supply issue brand change (Sep 24) [PDF 380 KB]
Expected resolution
The supplier, Pfizer, expects supply to return to normal by January 2025.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)